NVCR

10.7100.19%
UW

Uri Weinberg

Chief Innovation Officer & Chief Medical Officer

Dr. Uri Weinberg, M. D., Ph. D. serves as Chief Innovation Officer at NovoCure Limited since January 17, 2023 and also serves as its Chief Medical Officer since February 2026. He served as Chief Science Officer of NovoCure Limited until January 17, 2023. Since joining Novocure in 2008, he has held several positions throughout his tenure with the company. Dr. Weinberg managed Novocure’s first clinical trial in lung cancer as well as the EF-14 clinical trial in newly diagnosed glioblastoma and built the company’s global Clinical Operations team in Switzerland. Prior to becoming Chief Science Officer in March 2020, Dr. Weinberg most recently held the position of Vice President of Clinical Development where he was responsible for expanding research activities, strengthening global clinical collaboration and initiating new discovery programs. Dr. Weinberg holds an M. D. Ph. D. from the Technion – Israel Institute of Technology.

Positions